Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Residence Characteristics | 6 | 2017 | 224 | 1.680 |
Why?
|
| Pediatric Obesity | 3 | 2016 | 93 | 1.320 |
Why?
|
| Nursing Homes | 15 | 2024 | 665 | 1.180 |
Why?
|
| Environment | 3 | 2017 | 125 | 1.040 |
Why?
|
| Body Mass Index | 5 | 2017 | 886 | 0.940 |
Why?
|
| Stroke | 13 | 2023 | 1139 | 0.910 |
Why?
|
| Health Status | 3 | 2021 | 449 | 0.870 |
Why?
|
| Mexican Americans | 7 | 2015 | 19 | 0.730 |
Why?
|
| Food Supply | 2 | 2017 | 72 | 0.630 |
Why?
|
| Statistics as Topic | 1 | 2017 | 147 | 0.540 |
Why?
|
| Fast Foods | 1 | 2016 | 15 | 0.520 |
Why?
|
| Models, Statistical | 3 | 2016 | 307 | 0.520 |
Why?
|
| Feeding and Eating Disorders | 3 | 2022 | 47 | 0.520 |
Why?
|
| Environment Design | 1 | 2016 | 26 | 0.510 |
Why?
|
| Frailty | 3 | 2022 | 125 | 0.490 |
Why?
|
| Male | 40 | 2024 | 27578 | 0.470 |
Why?
|
| Medicare | 7 | 2024 | 601 | 0.470 |
Why?
|
| Brain Ischemia | 5 | 2017 | 403 | 0.460 |
Why?
|
| California | 7 | 2017 | 160 | 0.460 |
Why?
|
| Female | 41 | 2024 | 30924 | 0.450 |
Why?
|
| Models, Theoretical | 1 | 2016 | 258 | 0.450 |
Why?
|
| Memantine | 2 | 2024 | 23 | 0.440 |
Why?
|
| Cognitive Dysfunction | 3 | 2022 | 262 | 0.440 |
Why?
|
| Epidemics | 1 | 2013 | 22 | 0.430 |
Why?
|
| United States | 20 | 2024 | 7514 | 0.420 |
Why?
|
| Humans | 55 | 2024 | 59527 | 0.420 |
Why?
|
| Arthritis, Psoriatic | 2 | 2023 | 31 | 0.420 |
Why?
|
| Health Behavior | 1 | 2016 | 473 | 0.400 |
Why?
|
| Aged | 26 | 2024 | 13346 | 0.380 |
Why?
|
| Schools | 5 | 2017 | 156 | 0.380 |
Why?
|
| Spondylarthritis | 2 | 2023 | 42 | 0.380 |
Why?
|
| Antirheumatic Agents | 2 | 2024 | 213 | 0.360 |
Why?
|
| Aged, 80 and over | 18 | 2024 | 5092 | 0.360 |
Why?
|
| Atrial Fibrillation | 3 | 2024 | 798 | 0.350 |
Why?
|
| Child | 11 | 2024 | 4306 | 0.350 |
Why?
|
| Schizophrenia | 2 | 2021 | 256 | 0.330 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 325 | 0.320 |
Why?
|
| Physical Fitness | 3 | 2017 | 92 | 0.320 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 188 | 0.320 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2024 | 45 | 0.280 |
Why?
|
| Middle Aged | 21 | 2024 | 16279 | 0.280 |
Why?
|
| Sexism | 2 | 2024 | 31 | 0.270 |
Why?
|
| Sex Factors | 7 | 2024 | 960 | 0.270 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2017 | 125 | 0.260 |
Why?
|
| Cross-Sectional Studies | 10 | 2023 | 2470 | 0.250 |
Why?
|
| Stroke Rehabilitation | 2 | 2017 | 45 | 0.250 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 202 | 0.250 |
Why?
|
| Adolescent | 9 | 2024 | 5932 | 0.250 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 827 | 0.240 |
Why?
|
| Anticoagulants | 3 | 2024 | 487 | 0.240 |
Why?
|
| Physical Education and Training | 2 | 2017 | 31 | 0.240 |
Why?
|
| Risk Factors | 11 | 2024 | 5017 | 0.230 |
Why?
|
| Analgesics, Opioid | 3 | 2024 | 496 | 0.230 |
Why?
|
| Regression Analysis | 5 | 2017 | 484 | 0.230 |
Why?
|
| Insurance, Health | 2 | 2022 | 141 | 0.230 |
Why?
|
| Frail Elderly | 2 | 2022 | 110 | 0.220 |
Why?
|
| Texas | 7 | 2017 | 54 | 0.220 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2023 | 11 | 0.220 |
Why?
|
| Hospices | 1 | 2023 | 32 | 0.210 |
Why?
|
| Restaurants | 2 | 2013 | 28 | 0.210 |
Why?
|
| Delirium | 1 | 2023 | 56 | 0.210 |
Why?
|
| Hospice Care | 1 | 2023 | 59 | 0.200 |
Why?
|
| Dementia | 2 | 2024 | 247 | 0.200 |
Why?
|
| Retrospective Studies | 9 | 2024 | 6011 | 0.200 |
Why?
|
| Bulimia | 1 | 2022 | 15 | 0.200 |
Why?
|
| Rheumatology | 1 | 2022 | 65 | 0.200 |
Why?
|
| Prescription Drug Misuse | 1 | 2022 | 22 | 0.200 |
Why?
|
| Activities of Daily Living | 4 | 2017 | 298 | 0.190 |
Why?
|
| Geography, Medical | 1 | 2021 | 5 | 0.190 |
Why?
|
| Depression | 2 | 2019 | 857 | 0.190 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 312 | 0.190 |
Why?
|
| Quality of Life | 2 | 2021 | 1117 | 0.190 |
Why?
|
| Age Factors | 7 | 2022 | 1518 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2022 | 446 | 0.180 |
Why?
|
| Young Adult | 7 | 2024 | 4332 | 0.180 |
Why?
|
| Gender Identity | 1 | 2021 | 61 | 0.180 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 162 | 0.170 |
Why?
|
| Psychotic Disorders | 1 | 2021 | 151 | 0.170 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 141 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2021 | 715 | 0.170 |
Why?
|
| Cohort Studies | 5 | 2024 | 2442 | 0.170 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 208 | 0.160 |
Why?
|
| Anticonvulsants | 1 | 2020 | 95 | 0.160 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 116 | 0.160 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 212 | 0.160 |
Why?
|
| Mental Health Services | 1 | 2022 | 299 | 0.160 |
Why?
|
| Overweight | 2 | 2012 | 247 | 0.160 |
Why?
|
| Epilepsy | 1 | 2020 | 108 | 0.160 |
Why?
|
| Fibrinolytic Agents | 2 | 2017 | 165 | 0.160 |
Why?
|
| Cluster Analysis | 2 | 2023 | 250 | 0.160 |
Why?
|
| Adult | 11 | 2024 | 15791 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2020 | 223 | 0.150 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 691 | 0.150 |
Why?
|
| Hypertension | 3 | 2021 | 601 | 0.150 |
Why?
|
| Minority Groups | 1 | 2019 | 140 | 0.150 |
Why?
|
| Guideline Adherence | 3 | 2017 | 296 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 551 | 0.140 |
Why?
|
| Students | 1 | 2019 | 207 | 0.140 |
Why?
|
| Health Status Disparities | 2 | 2024 | 147 | 0.140 |
Why?
|
| Community-Based Participatory Research | 1 | 2017 | 46 | 0.140 |
Why?
|
| Propensity Score | 1 | 2017 | 134 | 0.140 |
Why?
|
| Cognition Disorders | 2 | 2017 | 218 | 0.130 |
Why?
|
| Spatial Analysis | 1 | 2016 | 7 | 0.130 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 330 | 0.130 |
Why?
|
| Recovery of Function | 2 | 2015 | 261 | 0.130 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 781 | 0.130 |
Why?
|
| Community Health Services | 1 | 2017 | 128 | 0.130 |
Why?
|
| Noninvasive Ventilation | 1 | 2016 | 70 | 0.120 |
Why?
|
| Bias | 1 | 2016 | 106 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 181 | 0.120 |
Why?
|
| Hospitalization | 1 | 2022 | 1283 | 0.120 |
Why?
|
| Mental Disorders | 1 | 2022 | 766 | 0.120 |
Why?
|
| Linear Models | 1 | 2016 | 422 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 864 | 0.120 |
Why?
|
| Social Support | 1 | 2017 | 358 | 0.120 |
Why?
|
| Population Surveillance | 4 | 2017 | 205 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 328 | 0.110 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 90 | 0.110 |
Why?
|
| Obesity | 2 | 2013 | 1186 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5184 | 0.110 |
Why?
|
| Health Promotion | 1 | 2017 | 491 | 0.100 |
Why?
|
| Administration, Oral | 2 | 2024 | 344 | 0.100 |
Why?
|
| Patient Discharge | 3 | 2022 | 479 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2022 | 3101 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 249 | 0.100 |
Why?
|
| Telemedicine | 1 | 2017 | 335 | 0.100 |
Why?
|
| Policy | 1 | 2012 | 47 | 0.100 |
Why?
|
| Physical Examination | 2 | 2022 | 103 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 474 | 0.090 |
Why?
|
| Comorbidity | 3 | 2021 | 1091 | 0.090 |
Why?
|
| Diet | 1 | 2016 | 635 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 456 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 1449 | 0.090 |
Why?
|
| Geriatric Assessment | 2 | 2022 | 161 | 0.090 |
Why?
|
| Legislation, Food | 1 | 2010 | 3 | 0.090 |
Why?
|
| Nutritional Requirements | 1 | 2010 | 30 | 0.090 |
Why?
|
| Ambulatory Care | 2 | 2022 | 300 | 0.090 |
Why?
|
| Prevalence | 3 | 2020 | 1281 | 0.080 |
Why?
|
| Pain | 2 | 2023 | 406 | 0.080 |
Why?
|
| Beverages | 1 | 2010 | 65 | 0.080 |
Why?
|
| Food | 1 | 2010 | 80 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1225 | 0.080 |
Why?
|
| School Health Services | 1 | 2010 | 62 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 2329 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2022 | 774 | 0.070 |
Why?
|
| Incidence | 3 | 2015 | 1238 | 0.070 |
Why?
|
| Cognition | 2 | 2023 | 459 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 2355 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 1 | 2024 | 46 | 0.060 |
Why?
|
| Population Health | 1 | 2024 | 15 | 0.060 |
Why?
|
| Censuses | 1 | 2023 | 14 | 0.060 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 101 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 921 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2023 | 99 | 0.050 |
Why?
|
| Biological Products | 1 | 2024 | 94 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 32 | 0.050 |
Why?
|
| Pain Management | 1 | 2024 | 145 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2024 | 277 | 0.050 |
Why?
|
| Georgia | 1 | 2022 | 88 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 271 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2024 | 275 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2592 | 0.050 |
Why?
|
| Chronic Pain | 1 | 2024 | 142 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 158 | 0.050 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 19 | 0.050 |
Why?
|
| Multilevel Analysis | 1 | 2021 | 7 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2021 | 40 | 0.050 |
Why?
|
| Age of Onset | 1 | 2021 | 172 | 0.050 |
Why?
|
| Myocardial Revascularization | 1 | 2021 | 71 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 351 | 0.050 |
Why?
|
| Data Collection | 1 | 2022 | 384 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2021 | 174 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 838 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 200 | 0.040 |
Why?
|
| Mortality | 1 | 2021 | 159 | 0.040 |
Why?
|
| Psychometrics | 1 | 2022 | 356 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 185 | 0.040 |
Why?
|
| Medicare Part D | 1 | 2020 | 35 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 152 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2021 | 183 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 155 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 673 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 250 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 1211 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 254 | 0.040 |
Why?
|
| Aging | 1 | 2024 | 723 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1551 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 18 | 0.040 |
Why?
|
| Registries | 1 | 2021 | 803 | 0.040 |
Why?
|
| Medicaid | 1 | 2021 | 335 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 1527 | 0.040 |
Why?
|
| Michigan | 1 | 2017 | 39 | 0.040 |
Why?
|
| Self Report | 1 | 2019 | 366 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 990 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 3579 | 0.030 |
Why?
|
| Survivors | 1 | 2017 | 148 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 537 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 107 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1252 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 108 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 526 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2019 | 519 | 0.030 |
Why?
|
| Crime | 1 | 2015 | 63 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 681 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 138 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1023 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 522 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1032 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 25 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 1489 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 286 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 2040 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 703 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2014 | 216 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 387 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 340 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 306 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 791 | 0.020 |
Why?
|
| Los Angeles | 1 | 2010 | 11 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 1915 | 0.020 |
Why?
|
| State Government | 1 | 2010 | 32 | 0.020 |
Why?
|
| Commerce | 1 | 2010 | 60 | 0.020 |
Why?
|